| Heartland Hospice Services 827 Fairways Court Suite 200, Stockbridge, GA, 30281 | |
| (770) 461-1658 |
News Archive
Young or middle-aged people with Atrial Fibrillation (AF), the most common heart rhythm abnormality, are at greater risk of death if they have other long-term health conditions, according to a new study.
India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).
› Verified 6 days ago
| Name | Heartland Hospice Services |
|---|---|
| Location | 827 Fairways Court Suite 200, Stockbridge, Georgia |
| Hospice ID | 111568 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 370 |
News Archive
Young or middle-aged people with Atrial Fibrillation (AF), the most common heart rhythm abnormality, are at greater risk of death if they have other long-term health conditions, according to a new study.
India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.4 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 70.6 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 95.1 | 97.3 |
| Patients who got timely treatment for shortness of breath | 96.8 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 94.3 | 93.3 |
News Archive
Young or middle-aged people with Atrial Fibrillation (AF), the most common heart rhythm abnormality, are at greater risk of death if they have other long-term health conditions, according to a new study.
India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).
› Verified 6 days ago
| Home Health Aides | 9.7 |
| Counselors | 2 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 2 |
| Registered Nurses | 7 |
| Other Personnel | 2 |
| Total Employees | 23.7 |
|---|
News Archive
Young or middle-aged people with Atrial Fibrillation (AF), the most common heart rhythm abnormality, are at greater risk of death if they have other long-term health conditions, according to a new study.
India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.
Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.
Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).
› Verified 6 days ago
| Gentiva Hospice Location: 216 Business Center Drive, Stockbridge, Georgia, 30281 Phone: (770) 461-1658 |
| Heartland Hospice Services Location: 827 Fairways Court Suite 200, Stockbridge, Georgia, 30281 Phone: (770) 461-1658 |
| Providence Hospice, Inc Location: 100 Corporate Center Drive Lower Level, Stockbridge, Georgia, 30281 Phone: (770) 461-1658 |
| Bridgeway Hospice Location: 354 Corporate Center Court, Stockbridge, Georgia, 30281 Phone: (770) 461-1658 |